tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Hoang, 40 are a BUY (70.18%), 12 are a HOLD (21.05%), 5 are a SELL (8.77%).
Analyst David Hoang, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 43.69% that have a potential upside of 24.77% achieved within 165 days. Previously, David Hoang worked at CITI.
David Hoang’s has documented 112 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings at 23-Feb-2026.
Analyst best performing recommendations are on LBPH (LONGBOARD PHARMACEUTICALS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 12/12/2023. The price target of $113 was fulfilled within 28 days with a profit of $26.19 (30.17%) receiving and performance score of 10.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Oct-2023
$16
$-0.7 (-4.19%)
$22
2 years 5 months 6 days ago
(05-Oct-2023)
1/2 (50%)
$0.05 (0.31%)
1
Buy Since 28-Mar-2023
$15
$-1.7 (-10.18%)
$15
2 years 8 months 12 days ago
(27-Jun-2023)
2/2 (100%)
$9.77 (186.81%)
146
Buy Since 14-Sep-2020
2 years 8 months 26 days ago
(13-Jun-2023)
1/2 (50%)
$88 (107.32%)
428
Buy Since 13-Mar-2023
$5
$-11.7 (-70.06%)
2 years 11 months 26 days ago
(13-Mar-2023)
1/1 (100%)
$0.05 (1.01%)
1
Buy Since 05-Sep-2019
$13
3 years 9 months 26 days ago
(13-May-2022)
1/2 (50%)
$-34.2 (-72.46%)
481
Which stock is David Hoang is most bullish on?
Which stock is David Hoang is most reserved on?
What Year was the first public recommendation made by David Hoang?
